← Back to Search

Behavioral Interventions for Alcoholism

N/A

Recruiting

Research Sponsored by University of Memphis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up enrollment, 12-months

Awards & highlights

Study Summary

This trial will test whether reducing stress and increasing engagement in positive activities can decrease alcohol use in non-student adults.

Who is the study for?

This trial is for non-student emerging adults aged 18-29 who drink heavily but aren't currently using drugs (except cannabis) or seeking addiction treatment. They must speak English, be able to read at a 9th-grade level, and have had multiple heavy drinking episodes recently.Check my eligibility

What is being tested?

The study tests if stress reduction and engaging in positive activities can help reduce alcohol use among young adults. It compares an educational control with substance-free activity sessions, brief alcohol interventions, and relaxation training.See study design

What are the potential side effects?

Since this trial involves behavioral interventions like education and relaxation techniques rather than medication, side effects are minimal but may include discomfort from discussing personal habits or slight anxiety during relaxation exercises.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ enrollment, 12-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~enrollment, 12-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment, 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from Baseline Alcohol Consumption and Drug Use at 1-month

Change from Baseline Alcohol Consumption and Drug Use at 12-months

Change from Baseline Alcohol Consumption and Drug Use at 3-months

+5 more

Secondary outcome measures

Anxiety

Change from Baseline Alcohol Purchase Task responses at 1-month

Change from Baseline Alcohol Purchase Task responses at 12-months

+13 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Relaxation Training (RT) + Substance Free Activity Session (SFAS)Experimental Treatment2 Interventions

Participants will complete a relaxation training session that will include a clinician leading them through a diaphragmatic breathing exercise, a progressive muscle relaxation protocol, and then a brief breath-counting (mindfulness) exercise. A week later, the participant will receive the SFAS, a 50-minute counseling session designed to increase the salience of the individual's goals, to highlight the connection between their current patterns of behavior (including drinking and substance-free activities) and the attainment of these goals, and to increase future orientation and engagement in enjoyable and goal-directed activities that are inconsistent with substance use (even if the participant has no desire to change their use).

Group II: Brief Alcohol Intervention (BAI) + Substance Free Activity Session (SFAS)Experimental Treatment2 Interventions

Participants first receive a 50-minute standard brief motivational intervention designed to reduce alcohol use. A week later, they will receive the Substance-free activity session (SFAS), a 50-minute counseling session designed to increase the salience of the individual's goals, to highlight the connection between their current patterns of behavior (including drinking and substance-free activities) and the attainment of these goals, and to increase future orientation and engagement in enjoyable and goal-directed activities that are inconsistent with substance use (even if the participant has no desire to change their use).

Group III: Education ControlActive Control1 Intervention

This minimal contact control condition will include a brief (2-3 minute) discussion where the research assistant (RA) who completed the assessment session will describe the educational handout. This condition is meant to approximate a public health-level approach to providing referral information and some of the content included in the BAI+SFAS condition but without any of the personalized information or motivational interviewing. Participants will receive information on risks associated with alcohol/drug misuse, strategies for reducing alcohol problems, managing stress, and goal-setting. The handout will also include links to hotlines, websites, and apps related to these domains. This condition will not include booster contact

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Relaxation Training (RT)

2009

N/A

~90

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MemphisLead Sponsor

70 Previous Clinical Trials

11,364 Total Patients Enrolled

1 Trials studying Alcoholism

393 Patients Enrolled for Alcoholism

Media Library

Brief Alcohol Intervention (BAI) Clinical Trial Eligibility Overview. Trial Name: NCT04776278 — N/A

Alcoholism Research Study Groups: Brief Alcohol Intervention (BAI) + Substance Free Activity Session (SFAS), Education Control, Relaxation Training (RT) + Substance Free Activity Session (SFAS)

Alcoholism Clinical Trial 2023: Brief Alcohol Intervention (BAI) Highlights & Side Effects. Trial Name: NCT04776278 — N/A

Brief Alcohol Intervention (BAI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04776278 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants presently being accepted for this trial?

"According to clinicaltrials.gov, this study is enrolling patients at the moment of writing. The trial was initially posted on January 17th 2022 and it has been updated as recently as May 16th 2022."

Answered by AI

Do you accept individuals older than 35 years for this research?

"This clinical trial is recruiting those aged 18-29 who meet the eligibility criteria."

Answered by AI

Is there an opportunity for me to participate in this research study?

"For this trial, 525 individuals aged 18 to 29 with alcoholism must be recruited. Furthermore, they are required to have consumed two or more alcoholic drinks in a single instance within the month prior and/or surpassing NIAAA's standards for high-risk drinking (14/7 beverages per week for men/women). Additionally, participants should possess at least ninth grade reading proficiency and cannot currently be attending nor planning on enrolling in any 4 year college institutions."

Answered by AI

What is the primary purpose of this clinical investigation?

"This medical trial's primary purpose is to assess modifications in participants' alcohol consumption and drug use after 12 months. As secondary aims, the research team will evaluate responses from an Alcohol Purchase Task (APT) at 6 and 12 months, as well as Anxiety & Stress Scale scores at 12-months. The APT involves asking patients how many standard drinks they would consume across 20 prices ($0-$20), with relative insensitivity ("inelastic" demand) being linked to risky drinking habits. Additionally, DASS subscale scores are expected to decrease following treatment using BAI+SFAS - these measurements serve as a mediator of outcomes too"

Answered by AI

How many participants are signing up for this medical research?

"Affirmative. The research project is actively recruiting patients, as evidenced by the information on clinicaltrials.gov which illustrates that in January 17th 2022 this study was first posted and subsequently updated on May 16th of this year. This medical trial desires to enrol 525 people from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Behavioral Economic and Wellness-based Approaches for Reducing Alcohol Use and Consequences Among Emerging Adults

James G Murphy 2022. "Behavioral Economic and Wellness-based Approaches for Reducing Alcohol Use and Consequences Among Emerging Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04776278.

All > Alcoholism